Deep-Dive Due Diligence AI Generated Probe of Calumet, Inc. Common Stock (CLMT)
Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.
These auto-generated reports apply OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.
35
$9.50
40
Turnaround
Mixed
Earnings report
C
energy, high short interest, insider activity, financial health concern
Calumet Struggles Amid Financial Turbulence, Insider Mixed Signals
CLMT_OUT_1 [2025-04-29 07:19:19 -0400] 5245 Bytes | 1482 tokens | Cum: 1482 tkns (18.52% of 8k)
==========================================================================
We're scouting for winners today. Its 7:19 AM on Tue Apr 29, 2025 and I'm looking at Calumet (CLMT) up to $11.62 from $10.48
Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.
--- COMPANY PROFILE ---
Company: Calumet (CLMT)
IPO: 2006-01-26 (19 Years Ago)
Market Cap: $776,726,133
Shares Outstanding: 86,210,000
Industry: PETROLEUM REFINING
Exchange: XNAS
Description: Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
Here’s a list of headlines for Calumet:
Apr-25-25 08:03AM - Calumet, Inc. to Release First Quarter 2025 Earnings on May 9, 2025
Apr-24-25 08:05AM - Calumet's Businesses Firing Like A Cannon, Well, Even Much Closer (Update)
Apr-14-25 09:59AM - Calumet, Inc. (CLMT): A Bull Case Theory
Apr-10-25 11:19AM - Calumet, Inc. (CLMT) Moves 12.5% Higher: Will This Strength Last?
Apr-01-25 08:15AM - Calumet Announces Closing of Sale of Assets Related to Industrial Portion of its Royal Purple Business
Mar-28-25 01:40PM - Valero's Exposure To Renewable Energy And More
Mar-17-25 05:59PM - Calumet Announces Intention to Nominate Julio Quintana and Karen Narwold to Board of Directors; and Wasserstein Debt Opportunities Expresses Support
Mar-04-25 04:00PM - Calumet to Attend Wolfe Research Conference
Mar-03-25 09:56AM - Here are Crossroads Capitals Updates on Calumet (CLMT)
Feb-28-25 07:17AM - Lubrication Engineers to Acquire Industrial Brands & Products of Royal Purple
Feb-28-25 07:17AM 07:05AM - Calumet Reports Fourth Quarter and Fiscal Year 2024 Results
Feb-28-25 07:17AM 07:00AM - Calumet Announces Sale of Assets Related to Industrial Portion of its Royal Purple Business
Feb-27-25 07:15AM - What To Expect From Calumet Inc (CLMT) Q4 2024 Earnings
Feb-19-25 09:07AM - Calumet to Attend Raymond James Conference
Feb-18-25 09:10AM - Montana Renewables Receives First Drawdown from $1.44 Billion DOE Loan Facility
Feb-14-25 07:00AM - Calumet, Inc. to Release Fourth Quarter and Fiscal Year 2024 Earnings on February 28, 2025
Jan-28-25 07:41PM - Calumet Says $1.44 Billion Loan Delayed on Trump Administration Review
Jan-28-25 07:41PM 06:25PM - Montana Renewables Announces Timing Update for DOE Loan Facility
Jan-15-25 09:37AM - Calumet Provides Update on Recent Financing Activity
Jan-14-25 07:35PM - Calumet Announces Pricing of $100 Million Private Placement of 9.75% Senior Notes due 2028
Jan-14-25 07:35PM 03:12PM - Calumet Inc (NASDAQ:CLMT): A Bullish Investment Perspective
Jan-14-25 07:35PM 09:27AM - Calumet Announces $100 Million Private Placement of 9.75% Senior Notes due 2028
Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.
B1 - 2024-11-06T11:00:00Z - Industrial Wax Market Size is Projected to Reach US$ 12,854 Million with 4.5% CAGR by 2034 | Fact.MR Report
B2 - 2024-10-22T15:29:00Z - 2 Energy Stocks on Upsurge After Securing Billion-Dollar DOE Loan Guarantees
B3 - 2024-05-28T19:55:55Z - WTI Crude Hits $80, Notches Best Day In Over 2 Months: 'Peak Oil Demand Still A Decade Away'
B4 - 2024-04-03T12:00:00Z - Rare Stock Picks In March 2024 - From 24 Discerning Analysts
B5 - 2023-11-22T15:06:50Z - HP, Iridium Communications And Other Big Stocks Moving Higher On Wednesday
B6 - 2023-11-09T18:13:05Z - Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
==============
-> THE ROLE FOR AI:
==============
1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Calumet (CLMT).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.
2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.
3) You will request information by referencing documents by their code.
4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.
5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.
Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.
NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`
CLMT_IN_2 [2025-04-29 07:19:19 -0400] 2 Bytes | 2 tokens | Cum: 1484 tkns (18.55% of 8k)
==========================================================================
B2
CLMT_OUT_3 [2025-04-29 07:19:20 -0400] 779 Bytes | 201 tokens | Cum: 1685 tkns (21.06% of 8k)
==========================================================================
Showing B2 (chunk 1 of 1): B2:
**2 Energy Stocks on Upsurge After Securing Billion-Dollar DOE Loan Guarantees**Date: Unknown DateSource: Unknown SourceURL: https://www.investing.com/analysis/2-energy-stocks-surging-on-billiondollar-doe-loan-commitments-200653285The U.S. Department of Energy (DOE) announced conditional loan guarantees of nearly $3 billion to fund projects for the production of sustainable aircraft fuel (SAF) by Calumet and Gevo. This news initially sent the stocks of these two companies surging higher.
Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.
CLMT_IN_4 [2025-04-29 07:19:20 -0400] 3 Bytes | 2 tokens | Cum: 1687 tkns (21.09% of 8k)
==========================================================================
NEX
CLMT_OUT_5 [2025-04-29 07:19:21 -0400] 955 Bytes | 310 tokens | Cum: 1997 tkns (24.96% of 8k)
==========================================================================
We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.
A1 - 2025-04-25T12:03:00Z - Calumet, Inc. to Release First Quarter 2025 Earnings on May 9, 2025...
A2 - 2025-04-25T12:07:51Z - Calumet, Inc. to Release First Quarter 2025 Earnings on May 9, 2025...
A3 - 2025-04-25T09:34:29Z - Stephen P. Mawer Sells 3,655 Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Stock...
A4 - 2025-04-24T18:45:01Z - Calumet Specialty Products Partners (NASDAQ:CLMT) Stock Price Down 2.8% - Here's What Happened...
A5 - 2025-04-18T17:58:07Z - Calumet Specialty Products Partners (NASDAQ:CLMT) Shares Up 5.2% - Here's What Happened...
Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.
CLMT_IN_6 [2025-04-29 07:19:21 -0400] 2 Bytes | 2 tokens | Cum: 1999 tkns (24.99% of 8k)
==========================================================================
A1
CLMT_OUT_7 [2025-04-29 07:19:22 -0400] 1181 Bytes | 352 tokens | Cum: 2351 tkns (29.39% of 8k)
==========================================================================
Showing A1 (chunk 1 of 3): A1:
**Calumet, Inc. to Release First Quarter 2025 Earnings on May 9, 2025**Date: 2025-04-25Source: {'uri': 'cnhinews.com', 'dataType': 'news', 'title': 'CNHI News'}URL: https://www.cnhinews.com/news/article_f1df9a4b-3b92-5d0c-9db0-df7548a81e8a.htmlINDIANAPOLIS, April 25, 2025 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to report results for the First Quarter 2025 on May 9, 2025. A conference call to discuss the financial and operational results is scheduled for May 9th at 9:00 AM ET.
Investors, analysts and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides; parties interested in listening to the webcast may follow the link which will be made available at http://calumetspecialty.investorroom.com/events. For
Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.
CLMT_IN_8 [2025-04-29 07:19:22 -0400] 3 Bytes | 2 tokens | Cum: 2353 tkns (29.41% of 8k)
==========================================================================
MOR
CLMT_OUT_9 [2025-04-29 07:19:22 -0400] 1181 Bytes | 284 tokens | Cum: 2637 tkns (32.96% of 8k)
==========================================================================
Showing A1 (chunk 2 of 3): those participants wishing to dial into the call, please pre-register by following the link: https://dpregister.com/sreg/10198598/fee1a3f082. A participant dial-in is also available toll-free at 1-844-695-5524 (US) or 1-412-317-0700 (International). When joining the call, please ask to be joined into the Calumet, Inc. call. A replay of the conference call will be available a few hours after the event on the investor relations section of the Company's website, under the events section.
About Calumet, Inc.
Calumet manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. Calumet is headquartered in Indianapolis, Indiana and operates twelve facilities throughout North America.
View original content:https://www.prnewswire.com/news-releases/calumet-inc-to-release-f
Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.
CLMT_IN_10 [2025-04-29 07:19:22 -0400] 3 Bytes | 2 tokens | Cum: 2639 tkns (32.99% of 8k)
==========================================================================
MOR
CLMT_OUT_11 [2025-04-29 07:19:23 -0400] 360 Bytes | 113 tokens | Cum: 2752 tkns (34.40% of 8k)
==========================================================================
Showing A1 (chunk 3 of 3): irst-quarter-2025-earnings-on-may-9-2025-302438359.html
SOURCE Calumet, Inc.
Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.
CLMT_IN_12 [2025-04-29 07:19:23 -0400] 3 Bytes | 2 tokens | Cum: 2754 tkns (34.42% of 8k)
==========================================================================
NEX
CLMT_OUT_13 [2025-04-29 07:19:24 -0400] 238 Bytes | 59 tokens | Cum: 2813 tkns (35.16% of 8k)
==========================================================================
This is our list of SEC filings.
If empty, the search returned no recent filings.
Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.
CLMT_IN_14 [2025-04-29 07:19:24 -0400] 14 Bytes | 3 tokens | Cum: 2816 tkns (35.20% of 8k)
==========================================================================
It seems there
CLMT_OUT_15 [2025-04-29 07:19:25 -0400] 251 Bytes | 78 tokens | Cum: 2894 tkns (36.18% of 8k)
==========================================================================
You just read a chunk of S1.
You may now:
- Say "MOR" to continue this article
- Say "S2", "S3", etc. to request another
- Or say "NEX" to move to the next source
You are allowed up to 6 articles from this list. If you’re ready to move on, say NEX.
CLMT_IN_16 [2025-04-29 07:19:25 -0400] 13 Bytes | 3 tokens | Cum: 2897 tkns (36.21% of 8k)
==========================================================================
It seems like
CLMT_OUT_17 [2025-04-29 07:19:32 -0400] 8606 Bytes | 2517 tokens | Cum: 5414 tkns (67.67% of 8k)
==========================================================================
This is our set of metrics for Calumet.
Please analyze the numbers.
+-------------------+-----------------------+-------------------------+-----------------------+
| Volume: 802,368 | Perf Month: -17.66% | Option/Short: Yes / Yes | Sales Y/Y TTM: 0.21% |
+-------------------+-----------------------+-------------------------+-----------------------+
| Avg Volume: 1.38M | Perf Quarter: -31.76% | Short Float: 12.91% | ROE: - |
+-------------------+-----------------------+-------------------------+-----------------------+
| Rel Volume: 0.58 | Index: - | Short Ratio: 6.42 | ROI: -14.36% |
+-------------------+-----------------------+-------------------------+-----------------------+
| RSI (14): 51.29 | Market Cap: 954.74M | Short Interest: 8.84M | Sales Surprise: 9.62% |
+-------------------+-----------------------+-------------------------+-----------------------+
| ATR (14): 0.95 | Shs Outstand: 85.95M | Beta: 0.89 | EPS Surprise: 35.32% |
+-------------------+-----------------------+-------------------------+-----------------------+
| SMA20: 7.09% | Shs Float: 68.47M | Sales Q/Q: -2.76% | P/E: - |
+-------------------+-----------------------+-------------------------+-----------------------+
| SMA50: -9.20% | Inst Own: 42.88% | Sales past 5Y: 8.55% | Earnings: May 09 BMO |
+-------------------+-----------------------+-------------------------+-----------------------+
| SMA200: -34.74% | Insider Own: 20.58% | Employees: 1620 | |
+-------------------+-----------------------+-------------------------+-----------------------+
| Perf Week: 20.12% | Insider Trans: -1.82% | Debt/Eq: - | |
+-------------------+-----------------------+-------------------------+-----------------------+
The next section covers any insider trading by Calumet officers or majority shareholders (if available).
Inside Trans: Calumet, Inc. /DE (CLMT) by Mawer Stephen P (Unknown Title) on 2025-04-22
- Common Stock, par value $0.01 per share: 3655 shares at $9.29 (D) Footnote: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024. The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $20.92 per share.
Inside Trans: Calumet, Inc. /DE (CLMT) by Borgmann Louis Todd (CHIEF EXECUTIVE OFFICER) on 2025-03-31
- Restricted Stock Unit: 9271 shares at $0 (D)
- Restricted Stock Units: 3090 shares at $0 (D)
Inside Trans: Calumet, Inc. /DE (CLMT) by Morical Gregory J (SVP, GENERAL COUNSEL) on 2025-03-31
- Restricted Stock Unit: 3595 shares at $0 (D)
- Restricted Stock Units: 1198 shares at $0 (D)
Inside Trans: Calumet, Inc. /DE (CLMT) by Lunin David (EVP - CFO) on 2025-03-31
- Restricted Stock Unit: 1890 shares at $0 (D)
- Restricted Stock Units: 630 shares at $0 (D)
Inside Trans: Calumet, Inc. /DE (CLMT) by Fleming Bruce A (EVP - MONTANA RENEWABLES) on 2025-03-31
- Restricted Stock Unit: 28320 shares at $0 (D)
- Restricted Stock Units: 9440 shares at $0 (D)
Inside Trans: Calumet, Inc. /DE (CLMT) by Mawer Stephen P (Unknown Title) on 2025-03-24
- Common Stock, par value $0.01 per share: 3655 shares at $12.88 (D) Footnote: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024.
Inside Trans: Calumet, Inc. /DE (CLMT) by DONARGO VINCENT (Chief Accounting Officer) on 2025-03-11
- Common Stock, par value $0.01 per share: 9024 shares at $0 (D)
- Common Stock, par value $0.01 per share: 4144 shares at $0 (D)
- Restricted Stock Unit: 9024 shares at $0 (D)
Inside Trans: Calumet, Inc. /DE (CLMT) by Morical Gregory J (SVP, GENERAL COUNSEL) on 2025-03-11
- Common Stock, par value $0.01 per share: 55634 shares at $0 (D)
- Common Stock, par value $0.01 per share: 24941 shares at $0 (D)
- Restricted Stock Unit: 55634 shares at $0 (D)
Inside Trans: Calumet, Inc. /DE (CLMT) by Fleming Bruce A (EVP - MONTANA RENEWABLES) on 2025-03-11
- Common Stock, par value $0.01 per share: 173066 shares at $0 (D)
- Common Stock, par value $0.01 per share: 68195 shares at $0 (D)
- Restricted Stock Unit: 173066 shares at $0 (D)
Inside Trans: Calumet, Inc. /DE (CLMT) by Mawer Stephen P (Unknown Title) on 2025-03-11
- Common Stock, par value $0.01 per share: 169937 shares at $0 (D)
- Common Stock, par value $0.01 per share: 75873 shares at $0 (D)
- Restricted Stock Unit: 169937 shares at $0 (D)
[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A
[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 1100400000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -100600000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A
[Price Metrics - Last 30 Days]
Latest Close: 11.075
Average Volume: 1353683.35
30-Day High: 13.15
30-Day Low: 8.99
[Detailed Financials: Q3 2024]
- Total Assets: $2,640,100,000.00
- Total Liabilities: $3,066,700,000.00
- Total Equity: $-672,200,000.00
- Current Assets: $789,800,000.00
- Current Liabilities: $1,254,400,000.00
[Income Statement: Q3 2024]
- Revenue: $1,100,400,000.00
- Net Income: $-100,600,000.00
- Gross Profit: $4,900,000.00
- Operating Income: $-57,100,000.00
- Earnings Per Share (EPS): -1.18
[Cash Flow Statement: Q3 2024]
- Net Cash Flow: N/A
[Detailed Financials: Q1 2024]
- Total Assets: $2,731,600,000.00
- Total Liabilities: $3,015,700,000.00
- Total Equity: $-529,700,000.00
- Current Assets: $811,700,000.00
- Current Liabilities: $824,400,000.00
[Income Statement: Q1 2024]
- Revenue: $1,005,800,000.00
- Net Income: $-41,600,000.00
- Gross Profit: $78,500,000.00
- Operating Income: $36,300,000.00
- Earnings Per Share (EPS): N/A
[Cash Flow Statement: Q1 2024]
- Net Cash Flow: $16,700,000.00
==== END OF FINANCIAL REPORT ====
You are now requested to write a summary analysis of Calumet (CLMT).
Please complete the report using the exact format:
FIELD[value]
1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Calumet.
2) MARKET_SCORE[]
This conversation was initiated because CLMT is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for CLMT.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.
3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, CLMT could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect CLMT to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]
4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.
5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.
6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)
7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.
8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.
9) SENTIMENT[]
bullish, bearish, neutral, or mixed
10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Calumet.
11) ETHICAL_RATING[]
Rate Calumet’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.
12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Calumet.
Provide any reasons you can use to support it.
Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.
Finally, thank you for participating!
CLMT_IN_18 [2025-04-29 07:19:32 -0400] 1182 Bytes | 253 tokens | Cum: 5667 tkns (70.84% of 8k)
==========================================================================
BRIEF_SUMMARY[Calumet has experienced significant negative performance over the past quarter and year, with a substantial drop of 31.76% and 34.74% respectively. Despite a minor year-over-year sales increase and positive earnings surprises, the company’s overall financial health appears strained, highlighted by negative ROI and ongoing net losses. Insider transactions suggest a mixed sentiment among top executives, with both acquisitions and sales of shares. The stock has seen some recovery in the short term, but the long-term outlook remains cautious due to high short interest and volatile market conditions.]
MARKET_SCORE[35]
PRICE_TARGET[9.50]
AI_RPT_HEADLINE[Calumet Struggles Amid Financial Turbulence, Insider Mixed Signals]
SQUEEZE_POTENTIAL[40]
TAGS[energy, high short interest, insider activity, financial health concern]
STOCK_TYPE[turnaround]
PRIMARY_CATALYST[earnings report]
SENTIMENT[mixed]
IMPROVEMENT_SUGGESTION[Detailed insights into the company's strategic plans for debt management and capital allocation would enhance the analysis.]
ETHICAL_RATING[C]
UPCOMING_CATALYST[Q1 2025 earnings report expected to influence share prices significantly]
CLMT_IN_19 [2025-04-29 07:19:32 -0400] 126 Bytes | 29 tokens | Cum: 5696 tkns (71.20% of 8k)
==========================================================================
====================================
[2025-04-29 07:19:32] # Analysis Completed
Elapsed Time: 13.99 seconds